Bernoulli C., Siegfried J., Baumgartner G., Regli F., Rabinowicz T., Gajdusek DC, et al. (1977). Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lanceti:478-479.
2.
Gibbs CJJr, Asher DM, Kobrine A., Amyx HL, Sulima MP, Gajdusek DC (1994). Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psych57:757-758. Manuelidis EE, Manuelidis L. (1993). A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population. Proc Natl Acad Sci USA90:7724-7728. Manuelidis EE, Kim JH, Mericagas JR, Manuelidis L. (1985). Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancetii:896-897.
3.
Manuelidis L., Sklaviadis T., Akowitz A., Fritch W. (1995). Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA92:5124-5128.
4.
Nisbett T., MacDonaldson I., Bishara S. (1989). Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. J Am Med Assoc261:1118.
5.
Oken RJ, McGeer PL (1995). Human prion diseases: possible new directions in prophylaxis and therapy. Med Hypotheses44:167-168.
6.
Prusiner SB, DeArmond SJ (1994). Prion diseases and neurodegeneration. Ann Rev Neurosci17:311-339. Rappaport EB (1987). Iatrogenic Creutzfeldt-Jakob disease. Neurology37:1520-1522.
7.
Steelman VC (1994). Creutzfeld-Jakob disease: recommendations for infection control. Am J Infect Control22:312-318.
8.
Taguchi F., Tamai Y., Uchida K., Kitajima R., Kojima H., Kawaguchi T., et al. (1991). Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch Virol119:297-301.
9.
Tateishi J. (1985). Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancetii:1074.
